Tamara Khokonova

Dr. Tamara Khokonova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2021 in Sports
Verified
Journal Article
Open access
PDF file
ZKZaira Kharaeva
Zaira Kharaeva
TKTamara Khokonova
Tamara Khokonova
JEJannet Elmurzaeva
Jannet Elmurzaeva
IDIrlana Dzamihova
Irlana Dzamihova
WMWolfgang Mayer
Wolfgang Mayer
Liudmila G. KorkinaLiudmila G. Korkina
Liudmila G. Korkina
Water depleted of heavy isotopes, such as 2H1 and 18O16 (HIDW), has shown numerous biological/health effects in vitro, in vivo, and in epidemiological studies. Major observations were related to cell growth/differentiation, immune/nervous system responses, endurance/adaptation, mitochondrial electron transfer, energy production, glucose metabolism, etc. No human studies to confirm physiological, metabolic, and immune responses to the consumption of HIDW have been performed. A placebo-controlled study on healthy volunteers (n = 50) under fitness load who consumed 1.5 L HIDW (58 ppm 2H and 1780 ppm 18O) or normal water for 60 days was carried out. Plasma content of 2H1 and 18O16, markers of energy, lipid, and glucose metabolism, anthropometric, cardio-vascular, oxidant/antioxidant, and immunological parameters were determined. Significant decrease in plasma heavy isotopes in the group consuming HIDW was observed in concomitance with an increase in ATP, insulin, and LDH, and diminished plasma lactate. Several anthropometric and cardio-vascular parameters were improved as compared to placebo group. Lipid markers demonstrated antiatherogenic effects, while oxidant/antioxidant parameters revealed HIDW-induced hormesis. Antibacterial/antiviral immunity was remarkably higher in HIDW versus placebo group. Conclusions: HIDW consumption by humans under fitness load could be a valid approach to improve their adaptation/recovery through several mechanisms.

8 May 2021 in Revista de la Universidad del Zulia
Verified
Journal Article
Open access
TKTamara Khokonova
Tamara Khokonova
SSSofiat Khasenovna Sizhazheva
Sofiat Khasenovna Sizhazheva
ZSZhaneta Huseynovna Sabanchieva
Zhaneta Huseynovna Sabanchieva
MNMarina Tembulatovna Nalchikova
Marina Tembulatovna Nalchikova
JEJannet Anvarovna Elmurzayeva
Jannet Anvarovna Elmurzayeva
SSSvetlana Sergeevna Solyanik
Svetlana Sergeevna Solyanik
Purpose. The work is devoted to study the effects of antihypertensive, lipid-lowering and metabolic therapy in office and the average hemodynamic parameters, the parameters of central pressure in the aorta, vascular wall stiffness and quality of life in patients with CKD stage 3 in combination with arterial hypertension of 1-2 degrees, and without it. Materials and methods. Were examined patients with arterial hypertension of 1-2 degrees and CKD stage 3. Measured hemodynamic parameters with the help of a daily BP monitor “BPLab”. The quality of life of patients was assessed by the questionnaire MOS SF36. Results. The greatest changes in the indicators of central hemodynamics and vascular stiffness were noted in the group of patients with comorbidity. Conclusion. The combination of antihypertensive therapy (losartan and diltiazem) with meldonium and rosuvastatin significantly decreases indices of central and peripheral hemodynamics and vascular stiffness. Add meldonium part of therapy significantly improves the quality of life of patients.

20 December 2020 in Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
Verified
Journal Article
Closed access
TKTamara Khokonova
Tamara Khokonova
ZKZaira Kharaeva
Zaira Kharaeva
RKRustam Khasanovich Keshokov
Rustam Khasanovich Keshokov
SSSofiat Khasenovna Sizhazheva
Sofiat Khasenovna Sizhazheva
SSSvetlana Sergeevna Solyanik
Svetlana Sergeevna Solyanik
The effect of antihypertensive and hypolipidemic therapy with the use of a fixed combination of amlodipine, lisinopril and rosuvastatin on the parameters of cytokines (the level of the proinflammatory cytokine - interleukin-1β, anti-inflammatory cytokine - interleukin-10, ligand CD40 (CD40L)), central aortic pressure, arterial stiffness and the value of albuminuria in patients with stage 3 chronic kidney disease, both in combination with arterial hypertension (AH) of 1-2 degrees, and without it, and in patients with coronary artery disease in combination with AH. The results of the study allow to conclude that the proposed antihypertensive and hypolipidemic therapy significantly reduces the parameters of central hemodynamics and vascular stiffness, the levels of microalbuminuria (MAU) and blood creatinine in patients with stage 3 chronic kidney disease in combination with AH of 1-2 degrees, and significantly increases the values IL-10 in patients with hypertension and CKD.